Establishment Labs Net Worth
Establishment Labs Net Worth Breakdown | ESTA |
Establishment Labs Net Worth Analysis
Establishment Labs' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Establishment Labs' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Establishment Labs' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Establishment Labs' net worth analysis. One common approach is to calculate Establishment Labs' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Establishment Labs' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Establishment Labs' net worth. This approach calculates the present value of Establishment Labs' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Establishment Labs' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Establishment Labs' net worth. This involves comparing Establishment Labs' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Establishment Labs' net worth relative to its peers.
Enterprise Value |
|
To determine if Establishment Labs is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Establishment Labs' net worth research are outlined below:
| Establishment Labs generated a negative expected return over the last 90 days | |
| Establishment Labs has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 166.03 M. Net Loss for the year was (84.6 M) with profit before overhead, payroll, taxes, and interest of 109.53 M. | |
| Establishment Labs Holdings currently holds about 65.35 M in cash with (58.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68. | |
| Establishment Labs has a frail financial position based on the latest SEC disclosures | |
| Over 89.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: What Is Establishment Labs Holdings Inc.s Share Price Doing |
Establishment Labs Quarterly Good Will |
|
Establishment Labs uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Establishment Labs Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Establishment Labs' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Establishment Labs Target Price Consensus
Establishment target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Establishment Labs' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Establishment analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Establishment stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Establishment Labs, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationEstablishment Labs Target Price Projection
Establishment Labs' current and average target prices are 41.18 and 60.29, respectively. The current price of Establishment Labs is the price at which Establishment Labs Holdings is currently trading. On the other hand, Establishment Labs' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Establishment Labs Market Quote on 25th of March 2025
Target Price
Analyst Consensus On Establishment Labs Target Price
Know Establishment Labs' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Establishment Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Establishment Labs Holdings backward and forwards among themselves. Establishment Labs' institutional investor refers to the entity that pools money to purchase Establishment Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bamco Inc | 2024-12-31 | 752.9 K | Millennium Management Llc | 2024-12-31 | 711.7 K | Balyasny Asset Management Llc | 2024-12-31 | 558.3 K | Jpmorgan Chase & Co | 2024-12-31 | 554.1 K | Polar Capital Holdings Plc | 2024-12-31 | 546.5 K | The Toronto-dominion Bank | 2024-12-31 | 540 K | Boothbay Fund Management, Llc | 2024-12-31 | 525.2 K | Mudita Advisors Llp | 2024-12-31 | 414.5 K | Ing Investment Management Llc | 2024-12-31 | 408.3 K | Jw Asset Management, Llc | 2024-12-31 | 3.1 M | Rtw Investments, Llc | 2024-12-31 | 2.6 M |
Follow Establishment Labs' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.19 B.Market Cap |
|
Project Establishment Labs' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.27) | |
| Return On Capital Employed | (0.18) | (0.17) | |
| Return On Assets | (0.24) | (0.26) | |
| Return On Equity | (1.59) | (1.51) |
When accessing Establishment Labs' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Establishment Labs' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Establishment Labs' profitability and make more informed investment decisions.
Please note, the presentation of Establishment Labs' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Establishment Labs' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Establishment Labs' management manipulating its earnings.
Evaluate Establishment Labs' management efficiency
Establishment Labs has return on total asset (ROA) of (0.1015) % which means that it has lost $0.1015 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.3666) %, meaning that it created substantial loss on money invested by shareholders. Establishment Labs' management efficiency ratios could be used to measure how well Establishment Labs manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.27. The current year's Return On Capital Employed is expected to grow to -0.17. At present, Establishment Labs' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 7.7 M, whereas Total Assets are forecasted to decline to about 176.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.90 | 1.05 | |
| Tangible Book Value Per Share | 1.44 | 0.86 | |
| Enterprise Value Over EBITDA | (21.33) | (22.40) | |
| Price Book Value Ratio | 24.21 | 25.42 | |
| Enterprise Value Multiple | (21.33) | (22.40) | |
| Price Fair Value | 24.21 | 25.42 | |
| Enterprise Value | 1.2 B | 760.6 M |
Understanding the operational decisions made by Establishment Labs management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 7.7052 | Revenue | Quarterly Revenue Growth 0.41 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Establishment Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on Establishment Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Establishment Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Establishment Labs Corporate Filings
F4 | 20th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 26th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify |
Establishment Labs Earnings Estimation Breakdown
The calculation of Establishment Labs' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Establishment Labs is estimated to be -0.8116 with the future projection ranging from a low of -0.8981 to a high of -0.76. Please be aware that this consensus of annual earnings estimates for Establishment Labs Holdings is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.9 Lowest | Expected EPS | -0.76 Highest |
Establishment Labs Earnings Projection Consensus
Suppose the current estimates of Establishment Labs' value are higher than the current market price of the Establishment Labs stock. In this case, investors may conclude that Establishment Labs is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Establishment Labs' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 7 | 79.12% | -1.19 | -0.8116 | -3.0 |
Establishment Labs Earnings History
Earnings estimate consensus by Establishment Labs analysts from Wall Street is used by the market to judge Establishment Labs' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Establishment Labs' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Establishment Labs Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Establishment Labs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Establishment Labs Earnings per Share Projection vs Actual
Actual Earning per Share of Establishment Labs refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Establishment Labs Holdings predict the company's earnings will be in the future. The higher the earnings per share of Establishment Labs, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Establishment Labs Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Establishment Labs, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Establishment Labs should always be considered in relation to other companies to make a more educated investment decision.Establishment Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Establishment Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-26 | 2024-12-31 | -0.656 | -1.19 | -0.534 | 81 | ||
2024-11-07 | 2024-09-30 | -0.61 | -0.59 | 0.02 | 3 | ||
2024-08-06 | 2024-06-30 | -0.51 | -0.62 | -0.11 | 21 | ||
2024-05-08 | 2024-03-31 | -0.67 | -0.58 | 0.09 | 13 | ||
2024-02-28 | 2023-12-31 | -0.91 | -0.79 | 0.12 | 13 | ||
2023-11-07 | 2023-09-30 | -0.8 | -1.12 | -0.32 | 40 | ||
2023-08-08 | 2023-06-30 | -0.72 | -0.65 | 0.07 | 9 | ||
2023-05-08 | 2023-03-31 | -0.68 | -0.48 | 0.2 | 29 | ||
2023-02-27 | 2022-12-31 | -0.68 | -0.55 | 0.13 | 19 | ||
2022-11-07 | 2022-09-30 | -0.54 | -0.76 | -0.22 | 40 | ||
2022-08-08 | 2022-06-30 | -0.4 | -1.52 | -1.12 | 280 | ||
2022-05-09 | 2022-03-31 | -0.38 | -0.24 | 0.14 | 36 | ||
2022-03-01 | 2021-12-31 | -0.33 | -0.6 | -0.27 | 81 | ||
2021-11-09 | 2021-09-30 | -0.35 | -0.61 | -0.26 | 74 | ||
2021-07-29 | 2021-06-30 | -0.28 | -0.22 | 0.06 | 21 | ||
2021-05-05 | 2021-03-31 | -0.34 | -0.29 | 0.05 | 14 | ||
2021-03-10 | 2020-12-31 | -0.19 | -0.23 | -0.04 | 21 | ||
2020-11-09 | 2020-09-30 | -0.35 | -0.18 | 0.17 | 48 | ||
2020-08-06 | 2020-06-30 | -0.45 | -0.45 | 0.0 | 0 | ||
2020-05-07 | 2020-03-31 | -0.31 | -0.79 | -0.48 | 154 | ||
2020-03-16 | 2019-12-31 | -0.59 | -0.27 | 0.32 | 54 | ||
2019-11-12 | 2019-09-30 | -0.5 | -0.62 | -0.12 | 24 | ||
2019-08-13 | 2019-06-30 | -0.53 | -0.44 | 0.09 | 16 | ||
2019-05-15 | 2019-03-31 | -0.46 | -0.53 | -0.07 | 15 | ||
2019-03-20 | 2018-12-31 | -0.36 | -0.52 | -0.16 | 44 | ||
2018-11-13 | 2018-09-30 | -0.36 | 0.06 | 0.42 | 116 | ||
2018-08-14 | 2018-06-30 | -0.5 | -0.35 | 0.15 | 30 | ||
2018-04-11 | 2018-03-31 | 0 | -1.95 | -1.95 | 0 |
Establishment Labs Corporate Management
| Heather Brennan | Head Operations | Profile | |
| Roberto Mezerville | Chief Officer | Profile | |
| Paul Rodio | Chief Officer | Profile | |
| Jeff Ehrhard | Senior America | Profile | |
| Jeff Ehrhardt | Senior America | Profile | |
| Ivan Bilic | Senior OUS | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Revenue Per Share | Quarterly Revenue Growth 0.41 | Return On Assets | Return On Equity |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.